Marina Chiara Garassino to Thymoma
This is a "connection" page, showing publications Marina Chiara Garassino has written about Thymoma.
Connection Strength
0.798
-
STYLE (NCT03449173): A Phase 2 Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines. J Thorac Oncol. 2023 08; 18(8):1070-1081.
Score: 0.226
-
Thymoma and thymic carcinoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations. Pediatr Blood Cancer. 2021 06; 68 Suppl 4:e29042.
Score: 0.197
-
RELEVENT Trial: Phase II Trial of Ramucirumab, Carboplatin, and Paclitaxel in Previously Untreated Thymic Carcinoma/B3 Thymoma With Area of Carcinoma. Clin Lung Cancer. 2018 09; 19(5):e811-e814.
Score: 0.162
-
Thymoma and thymic carcinomas. Crit Rev Oncol Hematol. 2016 Mar; 99:332-50.
Score: 0.137
-
Response of thymoma to cetuximab. Lancet Oncol. 2007 May; 8(5):449-50.
Score: 0.075